Back

Research

Cancer Research

Redefining Care

Sometimes, the standard of care is not enough. That’s when Grady research offers hope.

As one of the nation’s elite teaching hospitals, our clinicians are continually involved in research to find better, more effective treatments. We are committed to investigations that will ultimately end the cancer. Physicians, oncologists, surgeons, and other cancer experts from the Winship Cancer Institute at Emory, Emory and Morehouse schools of medicine, and Grady Health System collaborate on research whose mission is to improve cancer treatments, test the effectiveness of new drugs, and transform cancer care.

On any given day, our experts are involved in literally dozens of cancer studies – from clinical trials to laboratory experiments. Grady’s history of research has helped to redefine how physicians worldwide treat cancer, stroke and other diseases. The benefit to patients is clear: They have access to tomorrow’s medicine today, providing options unavailable at many other institutions.

The center earned the Quality Oncology Practice Initiative (QOPI) Certification which is awarded to outpatient hematology-oncology practices that meet the highest, national standards for delivering quality cancer care. Grady is the first public hospital in Georgia to receive this recognition.

ASCO qopi certification program Logo

Back to Top

Clinical Trials

Clinical trials are an important part of our research. While science provides more insight into the causes of cancer, clinical trials help translate this information into better care for cancer patients. Our patients have the opportunity to participate in clinical trials related to cancer prevention, diagnosis, and treatment.

Back to Top

BRCA 1 Gene Research

Dr. Veena N. Rao, Morehouse School of Medicine professor and co-director of the Cancer Biology Program in Grady’s OB/GYN Department, has dedicated her research to better understanding the BRCA1 gene and its mutations to improve the early detection and treatment of African American women with breast cancer.

Her research has led to the development of a patented technology, which when combined with BRCA1 DNA-based testing, promises to revolutionize early detection of hereditary triple negative breast cancers (TNBC), foster development of novel targeted therapies, and save countless lives.

Back to Top

Research at Grady

If you are interested in performing research at Grady, find out how to begin by visiting our Office of Research Administration.

Back to Top